http://orcid.org/0000-0001-9375-5821
References
- Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537
- Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67-119
- McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126(1 Suppl):14S-34S
- Vachiéry JL, Simonneau G. Management of severe pulmonary arterial hypertension. Eur Respir Rev 2010;19:279-87
- Farber HW, Miller DP, Poms, AD, et al. Five-year outcomes of patients enrolled in the REVEAL Registry. Chest 2015;148:1043-54
- Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S55-S66
- Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173:1023-30
- Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 2007;132:373-9
- Vachiéry JL, Gaine S. Challenges in the diagnosis and treatment of pulmonary arterial hypertension. Eur Respir Rev 2012;21:313-20
- Galiè N, Corris PA, Frost A, et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D60-72
- Baldi F, Fuso L, Arrighi E, et al. Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course. Ther Clin Risk Manag 2014;10:825-39
- Angalakuditi M, Edgell E, Beardsworth A, et al. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States. J Med Econ 2010;13:393-402
- Kirson NY, Birnbaum HG, Ivanova JI, et al. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population. Appl Health Econ Health Policy 2011;9:293-303
- Copher R, Cerulli A, Watkins A, et al. Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States. J Med Econ 2012;15:947-55
- Said Q, Martin BC, Joish VN, et al. The cost to managed care of managing pulmonary hypertension. J Med Econ 2012;15:500-8
- Odiz R, Langleben D. Cardiac catheterization in pulmonary arterial hypertension: an updated guide to proper use. Adv PH J 2005:4(3). http://www.phaonlineuniv.org/Journal/Article.cfm?Item-Number=645. [last accessed July 13, 2017]
- CMS_Stats_2013_final.pdf. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Archives/MMSS/2013.html. [last accessed September 28, 2015]
- Wilken H, Grimminger F, Hoeper, M, et al. Burden of pulmonary arterial hypertension in Germany. Respir Med 2010;104:902-10
- Channick RN, Delcroix M, Ghofrani, HA, et al. Effect of macitentan on hospitalizations: results from the SERAPHIN trial. J ACC Heart Fail 2015;3:1-8